News
MYNDF
0.068
NaN%
--
Weekly Report: what happened at MYNDF last week (0908-0912)?
Weekly Report · 09/15 10:55
Weekly Report: what happened at MYNDF last week (0901-0905)?
Weekly Report · 09/08 10:57
Weekly Report: what happened at MYNDF last week (0825-0829)?
Weekly Report · 09/01 10:53
Weekly Report: what happened at MYNDF last week (0818-0822)?
Weekly Report · 08/25 11:02
Weekly Report: what happened at MYNDF last week (0811-0815)?
Weekly Report · 08/18 10:56
Weekly Report: what happened at MYNDF last week (0804-0808)?
Weekly Report · 08/11 11:01
Weekly Report: what happened at MYNDF last week (0728-0801)?
Weekly Report · 08/04 11:04
Weekly Report: what happened at MYNDF last week (0721-0725)?
Weekly Report · 07/28 11:05
Weekly Report: what happened at MYNDF last week (0714-0718)?
Weekly Report · 07/21 10:55
Weekly Report: what happened at MYNDF last week (0707-0711)?
Weekly Report · 07/14 11:04
Weekly Report: what happened at MYNDF last week (0630-0704)?
Weekly Report · 07/07 10:56
Weekly Report: what happened at MYNDF last week (0623-0627)?
Weekly Report · 06/30 11:02
Weekly Report: what happened at MYNDF last week (0616-0620)?
Weekly Report · 06/23 10:56
Weekly Report: what happened at MYNDF last week (0609-0613)?
Weekly Report · 06/16 11:02
Weekly Report: what happened at MYNDF last week (0602-0606)?
Weekly Report · 06/09 11:03
Weekly Report: what happened at MYNDF last week (0526-0530)?
Weekly Report · 06/02 11:10
Weekly Report: what happened at MYNDF last week (0519-0523)?
Weekly Report · 05/26 11:10
Weekly Report: what happened at MYNDF last week (0512-0516)?
Weekly Report · 05/19 11:01
Weekly Report: what happened at MYNDF last week (0505-0509)?
Weekly Report · 05/12 11:02
Weekly Report: what happened at MYNDF last week (0428-0502)?
Weekly Report · 05/05 11:03
More
Webull provides a variety of real-time MYNDF stock news. You can receive the latest news about Mynd Life Scienc through multiple platforms. This information may help you make smarter investment decisions.
About MYNDF
MYND Life Sciences Inc. is Canada-based medical biotech drug research and development company. The Company is focused on neuro-pharmaceutical and novel psilocybin drug development, and diagnostics. The Company is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by molecular concepts for the applications of Psilocybins for overcoming disease. The Company is engaged in pharmaceutical developments through rigorous science and clinical trials while diligently patenting and safeguarding its intellectual property.